Have a personal or library account? Click to login
Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity Cover

Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity

The EuroBiotech Journal
Volume 5 (2021): Issue 1 (January 2021)
By: Ali Tuğrul Akin,  Emin Kaymak,  Emel Öztürk,  Derya Karabulut,  Nurhan Kuloğlu,  Tayfun Ceylan and  Ayşe Toluk  
Open Access
|Jan 2021

Figures & Tables

Figure 1. A, B

(A) Changes in the body weights of the experimental animals before and after the application of the experimental procedure. (B) Final body weights in the ADR group decreased significantly compared to the Control group, CLQ group and initial body weights of ADR group (p<0.05). Furthermore, body weight in the ADR+CLQ group were significantly higher compared to those of the ADR group (p<0.05). Histopathological scores showed a significant increase in the histopathological score in the ADR group when compared to the Control and CLQ group. However, it is also seen a significant decrease in the histopathological score in the ADR+CLQ group when compared to the ADR group. Abbreviations: ADR, Adriamycin; CLQ, Chloroquine.
(A) Changes in the body weights of the experimental animals before and after the application of the experimental procedure. (B) Final body weights in the ADR group decreased significantly compared to the Control group, CLQ group and initial body weights of ADR group (p<0.05). Furthermore, body weight in the ADR+CLQ group were significantly higher compared to those of the ADR group (p<0.05). Histopathological scores showed a significant increase in the histopathological score in the ADR group when compared to the Control and CLQ group. However, it is also seen a significant decrease in the histopathological score in the ADR+CLQ group when compared to the ADR group. Abbreviations: ADR, Adriamycin; CLQ, Chloroquine.

Figure 2 A-D

Light microscopy of liver tissue stained with H&E in experimental groups. (A) Control group (n=8) and (B) CLQ group (n=8), normal liver were observed; (C) ADR group (n=8), hemorrhage (yellow arrow), necrotic hepatocytes (red arrow), vacuolized hepatocytes (blue arrow), and irregular hepatocytes cords were observed; and (D) ADR+CLQ group, near to normal liver tissue were observed except for small hemorrhagic regions (yellow arrow); Scala bar: 50 μ. Magnification x200. Abbreviations: ADR, Adriamycin; CLQ, Chloroquine.
Light microscopy of liver tissue stained with H&E in experimental groups. (A) Control group (n=8) and (B) CLQ group (n=8), normal liver were observed; (C) ADR group (n=8), hemorrhage (yellow arrow), necrotic hepatocytes (red arrow), vacuolized hepatocytes (blue arrow), and irregular hepatocytes cords were observed; and (D) ADR+CLQ group, near to normal liver tissue were observed except for small hemorrhagic regions (yellow arrow); Scala bar: 50 μ. Magnification x200. Abbreviations: ADR, Adriamycin; CLQ, Chloroquine.

Figure 3 A-D

Immunohistochemical staining of IL-17 in the liver tissues and statistical analysis of the score of immunohistochemical staining in the experimental groups. (A) Control (n=8) and (B) CLQ (n=8) showed weak IL-17 immunostaining in the liver tissue sections; (C) ADR (n=8) group, IL-17 expression increased in the liver tissue. (D) ADR+CLQ (n=8) IL-17 expression was significantly decreased when compared to the ADR group. Arrows show the IL-17 immunopositive cells. Graph shows the statistical analysis of the score of immunohistochemical staining according to the following criteria: 0, no staining; 1, weak immunoreactivity; 2, moderate immunoreactivity; 3, strong immunoreactivity. Scala bar: 50 μ. Magnification x200. Abbreviations: ADR, Adriamycin; CLQ, Chloroquine.
Immunohistochemical staining of IL-17 in the liver tissues and statistical analysis of the score of immunohistochemical staining in the experimental groups. (A) Control (n=8) and (B) CLQ (n=8) showed weak IL-17 immunostaining in the liver tissue sections; (C) ADR (n=8) group, IL-17 expression increased in the liver tissue. (D) ADR+CLQ (n=8) IL-17 expression was significantly decreased when compared to the ADR group. Arrows show the IL-17 immunopositive cells. Graph shows the statistical analysis of the score of immunohistochemical staining according to the following criteria: 0, no staining; 1, weak immunoreactivity; 2, moderate immunoreactivity; 3, strong immunoreactivity. Scala bar: 50 μ. Magnification x200. Abbreviations: ADR, Adriamycin; CLQ, Chloroquine.

Initial and final body weights, histopathological, and IL-17 immunostaining score among experimental groups_

GroupsControlCLQADRADR+CLQp
Body weight (gr)Initial weight133±10.2128.3±15.6211.1±9.4166.5±14.50.001
Final weight270.3±19.8*223.7±45.8*137.7±13.7*176.6±20.40.001
Histopathological score (0 to 3)0.32±0.47a0.40±0.49a2.02±0.71b0.60±0.57a0.001
Score of IL-17 staining (0 to 3)0.55±0.51a0.45±0.51a1.90±0.64b0.70±0.65a0.001
DOI: https://doi.org/10.2478/ebtj-2021-0003 | Journal eISSN: 2564-615X
Journal RSS Feed
Language: English
Page range: 8 - 14
Published on: Jan 22, 2021
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Adriamycin,
chloroquine,
liver damage
Related subjects:
Life sciences,
Genetics,
Biotechnology,
Bioinformatics,
Life sciences, other

© 2021 Ali Tuğrul Akin, Emin Kaymak, Emel Öztürk, Derya Karabulut, Nurhan Kuloğlu, Tayfun Ceylan, Ayşe Toluk, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 5 (2021): Issue 1 (January 2021)Next article